198 related articles for article (PubMed ID: 29619923)
1. Clinical presentation, management and prognosis of patients with cardiac sarcoidosis.
Ghanizada M; Rossing K; Bundgaard H; Gustafsson F
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619923
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis.
Kazmirczak F; Chen KA; Adabag S; von Wald L; Roukoz H; Benditt DG; Okasha O; Farzaneh-Far A; Markowitz J; Nijjar PS; Velangi PS; Bhargava M; Perlman D; Duval S; Akçakaya M; Shenoy C
Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007488. PubMed ID: 31431050
[TBL] [Abstract][Full Text] [Related]
3. Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator.
Mohsen A; Jimenez A; Hood RE; Dickfeld T; Saliaris A; Shorofsky S; Saba MM
J Cardiovasc Electrophysiol; 2014 Feb; 25(2):171-6. PubMed ID: 24433308
[TBL] [Abstract][Full Text] [Related]
4. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres.
Fussner LA; Karlstedt E; Hodge DO; Fine NM; Kalra S; Carmona EM; Utz JP; Isaac DL; Cooper LT
Eur J Heart Fail; 2018 Dec; 20(12):1713-1720. PubMed ID: 30378224
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival.
Zhou Y; Lower EE; Li HP; Costea A; Attari M; Baughman RP
Chest; 2017 Jan; 151(1):139-148. PubMed ID: 27614001
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Sarcoidosis.
Tan JL; Fong HK; Birati EY; Han Y
Am J Cardiol; 2019 Feb; 123(3):513-522. PubMed ID: 30503798
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and clinical management of cardiac sarcoidosis.
Hamzeh N; Steckman DA; Sauer WH; Judson MA
Nat Rev Cardiol; 2015 May; 12(5):278-88. PubMed ID: 25707386
[TBL] [Abstract][Full Text] [Related]
8. Cardiac manifestations of sarcoidosis: diagnosis and management.
Birnie DH; Kandolin R; Nery PB; Kupari M
Eur Heart J; 2017 Sep; 38(35):2663-2670. PubMed ID: 27469375
[TBL] [Abstract][Full Text] [Related]
9. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
Skowasch D; Ringquist S; Nickenig G; Andrié R
PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
[TBL] [Abstract][Full Text] [Related]
10. Cardiac sarcoidosis: the Christchurch experience.
Adamson P; Melton I; O'Donnell J; MacDonald S; Crozier I
Intern Med J; 2014 Jan; 44(1):70-6. PubMed ID: 24450522
[TBL] [Abstract][Full Text] [Related]
11. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
Nery PB; Beanlands RS; Nair GM; Green M; Yang J; McArdle BA; Davis D; Ohira H; Gollob MH; Leung E; Healey JS; Birnie DH
J Cardiovasc Electrophysiol; 2014 Aug; 25(8):875-881. PubMed ID: 24602015
[TBL] [Abstract][Full Text] [Related]
12. Unusual Incessant Ventricular Tachycardia: What Is the Underlying Cause and the Possible Mechanism?
Shenthar J
Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1507-11. PubMed ID: 26671936
[No Abstract] [Full Text] [Related]
13. Diagnosis and treatment of cardiac sarcoidosis.
Kusano KF; Satomi K
Heart; 2016 Feb; 102(3):184-90. PubMed ID: 26643814
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
[TBL] [Abstract][Full Text] [Related]
15. Cardiac sarcoidosis: a potentially fatal but treatable form of infiltrative heart disease.
Chau EM; Fan KY; Chow WH
Hong Kong Med J; 2006 Feb; 12(1):65-7. PubMed ID: 16495592
[TBL] [Abstract][Full Text] [Related]
16. Update in Cardiac Sarcoidosis.
Ribeiro Neto ML; Jellis CL; Joyce E; Callahan TD; Hachamovitch R; Culver DA
Ann Am Thorac Soc; 2019 Nov; 16(11):1341-1350. PubMed ID: 31322914
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator.
Kron J; Sauer W; Mueller G; Schuller J; Bogun F; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA; Crawford T
J Interv Card Electrophysiol; 2015 Jun; 43(1):55-64. PubMed ID: 25676929
[TBL] [Abstract][Full Text] [Related]
18. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.
Betensky BP; Tschabrunn CM; Zado ES; Goldberg LR; Marchlinski FE; Garcia FC; Cooper JM
Heart Rhythm; 2012 Jun; 9(6):884-91. PubMed ID: 22338670
[TBL] [Abstract][Full Text] [Related]
20. Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- A propensity matched analysis.
Bandyopadhyay D; Sahoo D; Zein J; Brunken RC; Tchou PJ; Culver DA
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):70-9. PubMed ID: 26237358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
